

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * type I interferon signaling pathway (GO:0060337) | 5.79990975 |
| 2 | * cellular response to type I interferon (GO:0071357) | 5.79990975 |
| 3 | positive regulation of interferon-alpha production (GO:0032727) | 5.79798318 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.78409601 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.78409601 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.78409601 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.78409601 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.78409601 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.78409601 |
| 10 | * response to type I interferon (GO:0034340) | 5.76477950 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 5.44939617 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.43717390 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.43717390 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08848978 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.69211592 |
| 16 | negative regulation of viral genome replication (GO:0045071) | 4.67620239 |
| 17 | cellular response to interferon-alpha (GO:0035457) | 4.67499319 |
| 18 | * response to interferon-alpha (GO:0035455) | 4.66746377 |
| 19 | response to peptidoglycan (GO:0032494) | 4.64998418 |
| 20 | regulation of RIG-I signaling pathway (GO:0039535) | 4.59203325 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.45835412 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.37521436 |
| 23 | response to host immune response (GO:0052572) | 4.37521436 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.30251536 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29824781 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29824781 |
| 27 | cellular response to interferon-beta (GO:0035458) | 4.27072389 |
| 28 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.24971868 |
| 29 | cellular response to virus (GO:0098586) | 4.20981298 |
| 30 | positive regulation of type 2 immune response (GO:0002830) | 4.17477368 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16848563 |
| 32 | positive regulation of interferon-beta production (GO:0032728) | 4.15991295 |
| 33 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.15622248 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 4.15498957 |
| 35 | cellular response to exogenous dsRNA (GO:0071360) | 4.14889646 |
| 36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.13337178 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11485620 |
| 38 | detection of bacterium (GO:0016045) | 4.11186637 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09976214 |
| 40 | positive regulation of T cell cytokine production (GO:0002726) | 3.97242285 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94087669 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89515993 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88791431 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.87630140 |
| 45 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.84914243 |
| 46 | response to host (GO:0075136) | 3.84840109 |
| 47 | response to host defenses (GO:0052200) | 3.84840109 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.84840109 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76937761 |
| 50 | response to interferon-beta (GO:0035456) | 3.75733039 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75415666 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.73778352 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.73127847 |
| 54 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71555382 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.69188613 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.69188613 |
| 57 | cellular extravasation (GO:0045123) | 3.62530700 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.61321786 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.57842116 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.57492069 |
| 61 | leukocyte aggregation (GO:0070486) | 3.56032623 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.52895696 |
| 63 | microglial cell activation (GO:0001774) | 3.52103477 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 3.51567495 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.48940177 |
| 66 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.47401532 |
| 67 | germinal center formation (GO:0002467) | 3.46082283 |
| 68 | response to interleukin-15 (GO:0070672) | 3.45763511 |
| 69 | positive regulation of interleukin-12 production (GO:0032735) | 3.42928965 |
| 70 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.39326600 |
| 71 | granulocyte activation (GO:0036230) | 3.37661124 |
| 72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.36353617 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.35955103 |
| 74 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34683190 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.34549188 |
| 76 | * defense response to virus (GO:0051607) | 3.33404824 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 3.32749805 |
| 78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.31995711 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31056797 |
| 80 | positive regulation of response to biotic stimulus (GO:0002833) | 3.30112641 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.29671011 |
| 82 | B cell mediated immunity (GO:0019724) | 3.27515388 |
| 83 | response to protozoan (GO:0001562) | 3.26250619 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 3.25970650 |
| 85 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.20417003 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.18827520 |
| 87 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.18520654 |
| 88 | I-kappaB phosphorylation (GO:0007252) | 3.17946596 |
| 89 | neutrophil activation (GO:0042119) | 3.17455165 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 3.16972264 |
| 91 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.16375581 |
| 92 | B cell receptor signaling pathway (GO:0050853) | 3.13801949 |
| 93 | regulation of tolerance induction (GO:0002643) | 3.11722960 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11611178 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11500509 |
| 96 | cellular response to interferon-gamma (GO:0071346) | 3.11255511 |
| 97 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.10983453 |
| 98 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.08865386 |
| 99 | T-helper 1 type immune response (GO:0042088) | 3.07174025 |
| 100 | neutrophil mediated immunity (GO:0002446) | 3.06816363 |
| 101 | regulation of activation of Janus kinase activity (GO:0010533) | 3.06799693 |
| 102 | regulation of type 2 immune response (GO:0002828) | 3.03269282 |
| 103 | T cell migration (GO:0072678) | 3.03244916 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 3.02621251 |
| 105 | negative regulation of innate immune response (GO:0045824) | 3.01131596 |
| 106 | regulation of T cell cytokine production (GO:0002724) | 3.00543297 |
| 107 | regulation of interferon-beta production (GO:0032648) | 3.00136312 |
| 108 | regulation of interleukin-17 production (GO:0032660) | 2.98143810 |
| 109 | negative regulation of viral process (GO:0048525) | 2.98063824 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97760475 |
| 111 | regulation of defense response to virus by host (GO:0050691) | 2.92888778 |
| 112 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.92225555 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.91514649 |
| 114 | interferon-gamma secretion (GO:0072643) | 2.90110304 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89400509 |
| 116 | negative regulation of type 2 immune response (GO:0002829) | 2.88291168 |
| 117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88175378 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86444658 |
| 119 | respiratory burst (GO:0045730) | 2.84888622 |
| 120 | negative T cell selection (GO:0043383) | 2.84876626 |
| 121 | regulation of immunoglobulin secretion (GO:0051023) | 2.83899176 |
| 122 | regulation of antigen processing and presentation (GO:0002577) | 2.81825616 |
| 123 | negative regulation of interleukin-17 production (GO:0032700) | 2.80812627 |
| 124 | response to exogenous dsRNA (GO:0043330) | 2.80106249 |
| 125 | regulation of natural killer cell differentiation (GO:0032823) | 2.79297518 |
| 126 | detection of other organism (GO:0098543) | 2.78535839 |
| 127 | regulation of interleukin-12 production (GO:0032655) | 2.78270362 |
| 128 | macrophage activation (GO:0042116) | 2.78190675 |
| 129 | positive regulation of defense response to virus by host (GO:0002230) | 2.78155762 |
| 130 | response to interferon-gamma (GO:0034341) | 2.77063630 |
| 131 | defense response to protozoan (GO:0042832) | 2.75341872 |
| 132 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.74967069 |
| 133 | detection of external biotic stimulus (GO:0098581) | 2.74377880 |
| 134 | reactive oxygen species biosynthetic process (GO:1903409) | 2.73826237 |
| 135 | regulation of chemokine biosynthetic process (GO:0045073) | 2.73173429 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.72545356 |
| 137 | positive regulation of heat generation (GO:0031652) | 2.69577709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.34106159 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.73873196 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.69592927 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.09267344 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.17785707 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.10664560 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.95210406 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31578414 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26142136 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.11261403 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.02842962 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 3.01615075 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90778566 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75233751 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58364322 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58227167 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.47188296 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38922050 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.38324970 |
| 20 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32662342 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25718556 |
| 22 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06677901 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00478477 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98716899 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94869543 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84988908 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66618458 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61270493 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.60079595 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58799751 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57332563 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51440461 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49144422 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43831154 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42021197 |
| 36 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40712180 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39347327 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38117139 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34455415 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.34000072 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33031614 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33019629 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.32749376 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31738432 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31349930 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.30543977 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30026998 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26729266 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.23776407 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22557974 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21896975 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17902948 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16855637 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15313567 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15156509 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13633279 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13453355 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09251187 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08535504 |
| 60 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.05991051 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04555549 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03913571 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03358572 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02946369 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02913045 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01126452 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99682532 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99503743 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98457693 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98233828 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96692857 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96619788 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95745191 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93947247 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93707691 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92846891 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92721539 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92721539 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90286026 |
| 80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87944674 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86985068 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86951530 |
| 83 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86729821 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85237537 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83715662 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83311280 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81872657 |
| 88 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81399543 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80984564 |
| 90 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80847654 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80161697 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79799447 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77766511 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77078720 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75855206 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75629997 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75314214 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.74588819 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73418973 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71918747 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71609648 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70970995 |
| 103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70071465 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69980326 |
| 105 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69941649 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69748460 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69032424 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68547077 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68043784 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67233843 |
| 111 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66971955 |
| 112 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66440409 |
| 113 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.64907311 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63616265 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63090860 |
| 116 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62553168 |
| 117 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61997350 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61761420 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.61229538 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 0.59412571 |
| 121 | UTX_26944678_Chip-Seq_JUKART_Human | 0.58118935 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.57139897 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56581691 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.53503906 |
| 125 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.53478258 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52041571 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52028774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.36874780 |
| 2 | MP0009785_altered_susceptibility_to | 4.34752010 |
| 3 | MP0003724_increased_susceptibility_to | 3.65139605 |
| 4 | MP0003436_decreased_susceptibility_to | 3.28107232 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.19326114 |
| 6 | MP0000685_abnormal_immune_system | 3.19076036 |
| 7 | MP0006082_CNS_inflammation | 3.06111915 |
| 8 | MP0005025_abnormal_response_to | 3.04187893 |
| 9 | MP0001790_abnormal_immune_system | 3.01172209 |
| 10 | MP0005387_immune_system_phenotype | 3.01172209 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.81285365 |
| 12 | MP0002419_abnormal_innate_immunity | 2.79357413 |
| 13 | MP0003303_peritoneal_inflammation | 2.70656978 |
| 14 | MP0004510_myositis | 2.61709702 |
| 15 | MP0002723_abnormal_immune_serum | 2.36735833 |
| 16 | MP0001800_abnormal_humoral_immune | 2.36182522 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.35287056 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.30997422 |
| 19 | MP0005671_abnormal_response_to | 2.27431739 |
| 20 | MP0009840_abnormal_foam_cell | 2.25391043 |
| 21 | MP0009764_decreased_sensitivity_to | 2.21517556 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.06630352 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.03657106 |
| 24 | MP0004947_skin_inflammation | 1.99999629 |
| 25 | MP0005360_urolithiasis | 1.96104792 |
| 26 | MP0008469_abnormal_protein_level | 1.94693074 |
| 27 | MP0001819_abnormal_immune_cell | 1.92928619 |
| 28 | MP0001853_heart_inflammation | 1.91087623 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.90335254 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.85698648 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.80227207 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.75088900 |
| 33 | MP0000604_amyloidosis | 1.74346665 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.70258508 |
| 35 | MP0002006_tumorigenesis | 1.69199893 |
| 36 | MP0005083_abnormal_biliary_tract | 1.61895836 |
| 37 | MP0005451_abnormal_body_composition | 1.59689364 |
| 38 | MP0003075_altered_response_to | 1.58077768 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.51896220 |
| 40 | MP0002254_reproductive_system_inflammat | 1.48795234 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.47220477 |
| 42 | MP0002405_respiratory_system_inflammati | 1.45872077 |
| 43 | MP0003195_calcinosis | 1.44984358 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.43235381 |
| 45 | MP0009763_increased_sensitivity_to | 1.40960914 |
| 46 | MP0003448_altered_tumor_morphology | 1.40912160 |
| 47 | MP0000716_abnormal_immune_system | 1.39443966 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.35233304 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.33154893 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.31536739 |
| 51 | MP0008260_abnormal_autophagy | 1.31050754 |
| 52 | MP0009278_abnormal_bone_marrow | 1.30766409 |
| 53 | MP0000343_altered_response_to | 1.27947696 |
| 54 | MP0005365_abnormal_bile_salt | 1.26600396 |
| 55 | MP0002398_abnormal_bone_marrow | 1.24904665 |
| 56 | MP0003186_abnormal_redox_activity | 1.22792048 |
| 57 | MP0003866_abnormal_defecation | 1.21536729 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.19092247 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.19092247 |
| 60 | MP0003690_abnormal_glial_cell | 1.18939662 |
| 61 | MP0008004_abnormal_stomach_pH | 1.18838876 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.17604578 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.15404942 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.14364829 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.14332822 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.14230532 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.14167122 |
| 68 | MP0004883_abnormal_blood_vessel | 1.13754991 |
| 69 | MP0002429_abnormal_blood_cell | 1.07399386 |
| 70 | MP0003045_fibrosis | 1.06506221 |
| 71 | MP0005166_decreased_susceptibility_to | 1.05228732 |
| 72 | MP0005310_abnormal_salivary_gland | 1.05091722 |
| 73 | MP0003828_pulmonary_edema | 1.04561712 |
| 74 | MP0002132_abnormal_respiratory_system | 1.04095199 |
| 75 | MP0004381_abnormal_hair_follicle | 1.03167916 |
| 76 | MP0005164_abnormal_response_to | 1.02618904 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.01558291 |
| 78 | MP0000858_altered_metastatic_potential | 1.00162488 |
| 79 | MP0000609_abnormal_liver_physiology | 0.97814850 |
| 80 | MP0003252_abnormal_bile_duct | 0.96208428 |
| 81 | MP0004858_abnormal_nervous_system | 0.94838171 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.92491182 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.89444012 |
| 84 | MP0002722_abnormal_immune_system | 0.89353275 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.88700046 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88051549 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.87995086 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.87253871 |
| 89 | MP0003091_abnormal_cell_migration | 0.86450029 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.85555967 |
| 91 | MP0005390_skeleton_phenotype | 0.84342982 |
| 92 | MP0001663_abnormal_digestive_system | 0.83885309 |
| 93 | MP0001873_stomach_inflammation | 0.83832857 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.83185713 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.83161554 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.82574548 |
| 97 | MP0006054_spinal_hemorrhage | 0.80500044 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.79843922 |
| 99 | MP0001958_emphysema | 0.78561874 |
| 100 | MP0000249_abnormal_blood_vessel | 0.78062690 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.77204788 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75650428 |
| 103 | MP0010307_abnormal_tumor_latency | 0.75511394 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.73049737 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.72885599 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.72740567 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70065838 |
| 108 | MP0000371_diluted_coat_color | 0.69704103 |
| 109 | MP0002933_joint_inflammation | 0.68701499 |
| 110 | MP0005332_abnormal_amino_acid | 0.68616409 |
| 111 | MP0003646_muscle_fatigue | 0.67177560 |
| 112 | MP0008874_decreased_physiological_sensi | 0.67097369 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.65582564 |
| 114 | MP0000598_abnormal_liver_morphology | 0.64657696 |
| 115 | MP0001851_eye_inflammation | 0.64169940 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.64035352 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.61876771 |
| 118 | MP0000767_abnormal_smooth_muscle | 0.61679351 |
| 119 | MP0001881_abnormal_mammary_gland | 0.60566272 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.59531627 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.58889045 |
| 122 | MP0003795_abnormal_bone_structure | 0.57080366 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.55050481 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.53828822 |
| 125 | MP0001501_abnormal_sleep_pattern | 0.51412958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.51554900 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.49343372 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.47949755 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.42516799 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.75123435 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.66204064 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.58842193 |
| 8 | Orchitis (HP:0100796) | 4.45908538 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.31581124 |
| 10 | Optic neuritis (HP:0100653) | 4.31581124 |
| 11 | Myositis (HP:0100614) | 4.23452107 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.23181057 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.16535680 |
| 14 | Increased IgM level (HP:0003496) | 4.07030996 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.01252395 |
| 16 | Recurrent skin infections (HP:0001581) | 3.88012357 |
| 17 | Vasculitis (HP:0002633) | 3.81274532 |
| 18 | Encephalitis (HP:0002383) | 3.80519078 |
| 19 | Basal ganglia calcification (HP:0002135) | 3.71481007 |
| 20 | T lymphocytopenia (HP:0005403) | 3.57682822 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.49579058 |
| 22 | Chronic otitis media (HP:0000389) | 3.47638713 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.44655935 |
| 24 | Recurrent viral infections (HP:0004429) | 3.40142648 |
| 25 | Gingival bleeding (HP:0000225) | 3.33390853 |
| 26 | Joint hemorrhage (HP:0005261) | 3.24935711 |
| 27 | Gingivitis (HP:0000230) | 3.23878899 |
| 28 | Increased IgE level (HP:0003212) | 3.14659596 |
| 29 | Stomatitis (HP:0010280) | 3.12590732 |
| 30 | Periodontitis (HP:0000704) | 3.12145463 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.11792867 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.10077633 |
| 33 | Porencephaly (HP:0002132) | 3.09368855 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.09237279 |
| 35 | Myocardial infarction (HP:0001658) | 3.07285570 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98214793 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96180226 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96180226 |
| 39 | Tetraparesis (HP:0002273) | 2.95399863 |
| 40 | Prostate neoplasm (HP:0100787) | 2.95205879 |
| 41 | Arterial thrombosis (HP:0004420) | 2.94351623 |
| 42 | Chest pain (HP:0100749) | 2.91834031 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.90037216 |
| 44 | Thick nail (HP:0001805) | 2.87803313 |
| 45 | Abnormality of T cells (HP:0002843) | 2.84033416 |
| 46 | Axonal loss (HP:0003447) | 2.75680099 |
| 47 | Pustule (HP:0200039) | 2.74836499 |
| 48 | Episodic fever (HP:0001954) | 2.73255034 |
| 49 | Abnormality of the pleura (HP:0002103) | 2.72754644 |
| 50 | Joint swelling (HP:0001386) | 2.70040152 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.69450813 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.69134249 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.68788188 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.67527356 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.66037703 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.65739059 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.63150569 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.60513720 |
| 59 | Hypochromic anemia (HP:0001931) | 2.59174720 |
| 60 | Complement deficiency (HP:0004431) | 2.57588163 |
| 61 | Glomerulonephritis (HP:0000099) | 2.56102771 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.53808619 |
| 63 | Peritonitis (HP:0002586) | 2.52715826 |
| 64 | Nephritis (HP:0000123) | 2.51643969 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50272138 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50272138 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50272138 |
| 68 | Hemoptysis (HP:0002105) | 2.49501933 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.49249839 |
| 70 | Lymphopenia (HP:0001888) | 2.48350768 |
| 71 | Amyloidosis (HP:0011034) | 2.47780178 |
| 72 | Granulocytopenia (HP:0001913) | 2.47050188 |
| 73 | Nasal polyposis (HP:0100582) | 2.44511903 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43556303 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.41657548 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.39580836 |
| 77 | Leukocytosis (HP:0001974) | 2.36649166 |
| 78 | Urticaria (HP:0001025) | 2.36416161 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35796117 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.35717177 |
| 81 | Loss of speech (HP:0002371) | 2.35636249 |
| 82 | Esophageal varix (HP:0002040) | 2.34751781 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.34447826 |
| 84 | Xanthomatosis (HP:0000991) | 2.32208405 |
| 85 | Deep venous thrombosis (HP:0002625) | 2.31484550 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.31395670 |
| 87 | Keratitis (HP:0000491) | 2.30614077 |
| 88 | Osteomyelitis (HP:0002754) | 2.29579948 |
| 89 | Gastrointestinal stroma tumor (HP:0100723) | 2.29174829 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 2.28663555 |
| 91 | Purpura (HP:0000979) | 2.27725401 |
| 92 | Thrombophlebitis (HP:0004418) | 2.25081450 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.24954858 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.23473691 |
| 95 | Polyneuropathy (HP:0001271) | 2.22421731 |
| 96 | Vertigo (HP:0002321) | 2.22022430 |
| 97 | Obstructive lung disease (HP:0006536) | 2.19962377 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19962377 |
| 99 | Agammaglobulinemia (HP:0004432) | 2.18258093 |
| 100 | Plagiocephaly (HP:0001357) | 2.17845611 |
| 101 | Abnormality of complement system (HP:0005339) | 2.17744526 |
| 102 | Abnormality of the peritoneum (HP:0002585) | 2.16823326 |
| 103 | Mitral stenosis (HP:0001718) | 2.16748925 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16344367 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.15545846 |
| 106 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.15469459 |
| 107 | Anorexia (HP:0002039) | 2.15215317 |
| 108 | Glomerulopathy (HP:0100820) | 2.14692397 |
| 109 | Sepsis (HP:0100806) | 2.13763590 |
| 110 | Recurrent bronchitis (HP:0002837) | 2.13632935 |
| 111 | Intrahepatic cholestasis (HP:0001406) | 2.13228799 |
| 112 | Bone pain (HP:0002653) | 2.13179056 |
| 113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10408853 |
| 114 | Meningitis (HP:0001287) | 2.09165209 |
| 115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08032135 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.08032135 |
| 117 | Abnormality of eosinophils (HP:0001879) | 2.08030046 |
| 118 | Cellulitis (HP:0100658) | 2.07440126 |
| 119 | Recurrent pneumonia (HP:0006532) | 2.06386019 |
| 120 | Pathologic fracture (HP:0002756) | 2.06276508 |
| 121 | IgG deficiency (HP:0004315) | 2.06158267 |
| 122 | Eosinophilia (HP:0001880) | 2.03759036 |
| 123 | Acne (HP:0001061) | 2.03630399 |
| 124 | Abnormality of T cell number (HP:0011839) | 2.01340622 |
| 125 | Petechiae (HP:0000967) | 2.01177600 |
| 126 | Hematochezia (HP:0002573) | 2.01141280 |
| 127 | Epistaxis (HP:0000421) | 2.00945859 |
| 128 | Pulmonary embolism (HP:0002204) | 1.99527751 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.98771219 |
| 130 | Spontaneous abortion (HP:0005268) | 1.98727809 |
| 131 | Spastic tetraparesis (HP:0001285) | 1.98211878 |
| 132 | Arthralgia (HP:0002829) | 1.97313871 |
| 133 | Acute hepatic failure (HP:0006554) | 1.95334811 |
| 134 | Gangrene (HP:0100758) | 1.93732884 |
| 135 | Lower limb hyperreflexia (HP:0002395) | 1.93486552 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.93467400 |
| 137 | Increased serum ferritin (HP:0003281) | 1.91978665 |
| 138 | Skin ulcer (HP:0200042) | 1.91754170 |
| 139 | Cheilitis (HP:0100825) | 1.91665368 |
| 140 | Colitis (HP:0002583) | 1.90270256 |
| 141 | Prolonged neonatal jaundice (HP:0006579) | 1.89371126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 5.01555611 |
| 2 | MAP3K14 | 4.49093361 |
| 3 | IKBKE | 4.18199509 |
| 4 | TBK1 | 3.86641767 |
| 5 | JAK1 | 3.31628314 |
| 6 | JAK3 | 3.30927047 |
| 7 | RIPK4 | 3.20531217 |
| 8 | PBK | 2.97232018 |
| 9 | IRAK4 | 2.90070998 |
| 10 | FGFR4 | 2.89907512 |
| 11 | MAP3K13 | 2.76698352 |
| 12 | BLK | 2.73881284 |
| 13 | KIT | 2.60083001 |
| 14 | ERN1 | 2.37670748 |
| 15 | IKBKB | 2.31772563 |
| 16 | IRAK3 | 2.31143064 |
| 17 | MAP2K3 | 2.17120540 |
| 18 | MAP4K1 | 2.03283151 |
| 19 | TXK | 2.02148683 |
| 20 | TNK2 | 1.89584209 |
| 21 | PRPF4B | 1.84637571 |
| 22 | CHUK | 1.55429319 |
| 23 | TAOK3 | 1.54028892 |
| 24 | FGFR3 | 1.51475781 |
| 25 | PIM2 | 1.48199491 |
| 26 | CSK | 1.47498496 |
| 27 | TAOK1 | 1.46297342 |
| 28 | GRK7 | 1.43672737 |
| 29 | GRK6 | 1.42237102 |
| 30 | EPHB1 | 1.34932051 |
| 31 | IRAK1 | 1.25004598 |
| 32 | ZAP70 | 1.23466642 |
| 33 | TAOK2 | 1.19509683 |
| 34 | SYK | 1.18498220 |
| 35 | EIF2AK2 | 1.17230121 |
| 36 | JAK2 | 1.15426809 |
| 37 | HCK | 1.13736156 |
| 38 | FRK | 1.09774053 |
| 39 | EPHA3 | 1.09586983 |
| 40 | CDC42BPA | 1.01587293 |
| 41 | BMPR2 | 1.00740228 |
| 42 | LCK | 0.98455525 |
| 43 | IRAK2 | 0.97561094 |
| 44 | CSF1R | 0.96153875 |
| 45 | LYN | 0.90770354 |
| 46 | MST1R | 0.89616107 |
| 47 | MST4 | 0.89492892 |
| 48 | MAP3K5 | 0.86306645 |
| 49 | SIK1 | 0.84391607 |
| 50 | ABL2 | 0.82545028 |
| 51 | RPS6KA4 | 0.82182917 |
| 52 | MATK | 0.80533353 |
| 53 | ARAF | 0.80423907 |
| 54 | FGR | 0.79729927 |
| 55 | BTK | 0.75490791 |
| 56 | MARK2 | 0.74806942 |
| 57 | MARK3 | 0.74629702 |
| 58 | HIPK2 | 0.73085381 |
| 59 | NEK9 | 0.72204172 |
| 60 | FES | 0.71362035 |
| 61 | ERBB4 | 0.67204788 |
| 62 | TRPM7 | 0.65775579 |
| 63 | PIM1 | 0.65071526 |
| 64 | MAPK7 | 0.63935888 |
| 65 | NME2 | 0.63905005 |
| 66 | MAPK11 | 0.63246921 |
| 67 | PTK2B | 0.62935406 |
| 68 | SIK2 | 0.62433184 |
| 69 | TEC | 0.62001122 |
| 70 | BMX | 0.61930216 |
| 71 | PRKD2 | 0.61441745 |
| 72 | EGFR | 0.61080984 |
| 73 | KSR2 | 0.60698225 |
| 74 | SIK3 | 0.60626622 |
| 75 | DAPK2 | 0.59901488 |
| 76 | MAP2K6 | 0.59263821 |
| 77 | PRKCQ | 0.58118369 |
| 78 | MAP3K7 | 0.58076482 |
| 79 | STK4 | 0.57926771 |
| 80 | FLT3 | 0.56608312 |
| 81 | INSRR | 0.56514361 |
| 82 | ACVR1B | 0.56115136 |
| 83 | TGFBR2 | 0.55286421 |
| 84 | MAP3K6 | 0.53569104 |
| 85 | PRKCD | 0.51781535 |
| 86 | PTK6 | 0.51386496 |
| 87 | ABL1 | 0.50917923 |
| 88 | STK3 | 0.45927401 |
| 89 | CAMKK2 | 0.44585542 |
| 90 | TTN | 0.40609656 |
| 91 | MAP3K11 | 0.40558988 |
| 92 | MAP3K10 | 0.39445094 |
| 93 | STK11 | 0.39192164 |
| 94 | PKN1 | 0.38278731 |
| 95 | PIK3CG | 0.36853996 |
| 96 | TRIB3 | 0.35569369 |
| 97 | DAPK3 | 0.35368344 |
| 98 | RIPK1 | 0.33694052 |
| 99 | MAPK12 | 0.33155237 |
| 100 | MAP3K1 | 0.32693191 |
| 101 | ERBB3 | 0.30935259 |
| 102 | STK10 | 0.30626026 |
| 103 | MELK | 0.29524556 |
| 104 | DDR2 | 0.28320940 |
| 105 | SGK3 | 0.28105056 |
| 106 | RPS6KA5 | 0.28088035 |
| 107 | MAP3K3 | 0.28001819 |
| 108 | YES1 | 0.27454286 |
| 109 | MOS | 0.27066979 |
| 110 | RPS6KA6 | 0.27032353 |
| 111 | CAMK1D | 0.27001968 |
| 112 | SGK2 | 0.25726895 |
| 113 | RPS6KC1 | 0.25325017 |
| 114 | RPS6KL1 | 0.25325017 |
| 115 | KDR | 0.25029331 |
| 116 | STK38 | 0.24921193 |
| 117 | DYRK1B | 0.24622003 |
| 118 | NUAK1 | 0.24255678 |
| 119 | CDK4 | 0.24251808 |
| 120 | IGF1R | 0.23932788 |
| 121 | NLK | 0.23158125 |
| 122 | PRKAA2 | 0.22751442 |
| 123 | MET | 0.22501219 |
| 124 | ITK | 0.20709548 |
| 125 | BCKDK | 0.20346151 |
| 126 | PRKG2 | 0.20136528 |
| 127 | CDK6 | 0.19190962 |
| 128 | PDPK1 | 0.18750427 |
| 129 | FYN | 0.18290599 |
| 130 | INSR | 0.17826666 |
| 131 | ADRBK2 | 0.16894167 |
| 132 | PDK1 | 0.16348226 |
| 133 | PDGFRB | 0.16277936 |
| 134 | MAPKAPK2 | 0.13665713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.21390643 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.13118178 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.05643346 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.93904557 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.86915193 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78943968 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.68184559 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.67621405 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65400692 |
| 10 | Influenza A_Homo sapiens_hsa05164 | 2.52451086 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26826476 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11880768 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08761886 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.04760973 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.02251276 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 2.00237666 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.98644028 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.95659206 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90742890 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85767329 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85198083 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.82741515 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79985565 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78076213 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.76501623 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.62209127 |
| 27 | Hepatitis C_Homo sapiens_hsa05160 | 1.59443767 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55423771 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39539962 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37264532 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27795705 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27132822 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26130663 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23266720 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15636489 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.14582620 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13924885 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.12617561 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.12237711 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.11504524 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09412872 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08851231 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.07966946 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07306056 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.06298926 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02367996 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99340449 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98751156 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98723447 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92370397 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90600821 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.89586244 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.85328143 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.84935515 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84576204 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79957858 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79613721 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79308081 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.79279086 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.75507154 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68804106 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66123833 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65985796 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.65613210 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65047726 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64395705 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63808308 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61833436 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58452977 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56028550 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55303184 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55002701 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54347048 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53715468 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52023217 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51955830 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50632875 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50497495 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50344149 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49136112 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46505852 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43653204 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42548685 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42340248 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40984685 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40099195 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39695210 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39220747 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38953598 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38105556 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37832785 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37009441 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.36967764 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36946717 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.36895255 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36467175 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35160753 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34562997 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34202644 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33483631 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33106722 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32955225 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32895615 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31213868 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31136091 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30621170 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30568361 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30537139 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30135085 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29621004 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29068428 |
| 112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28864343 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28109171 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28016497 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27250267 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27247542 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26946885 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26887516 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25738891 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24975426 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24446028 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24400678 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24095997 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22423655 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.22382155 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21296500 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.20780604 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18240999 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17534651 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.17463159 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17032527 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17005626 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16429487 |

